Production (Stage)
Artelo Biosciences, Inc.
ARTL
$0.9527
-$0.0023-0.24%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.72M | -9.83M | -9.12M | -10.44M | -9.60M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 654.00K | 569.00K | 455.00K | 367.00K | 293.00K |
| Change in Net Operating Assets | 2.06M | 907.00K | 287.00K | 668.00K | 348.00K |
| Cash from Operations | -7.01M | -8.35M | -8.38M | -9.40M | -8.96M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 6.50M | 7.77M | 10.01M | 3.93M | 2.58M |
| Cash from Investing | 6.50M | 7.77M | 10.01M | 3.93M | 2.58M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 57.00K | 112.00K | 87.00K | 622.00K | 622.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 57.00K | 112.00K | 87.00K | 622.00K | 622.00K |
| Foreign Exchange rate Adjustments | -1.00K | -8.00K | 0.00 | 15.00K | 43.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -449.00K | -477.00K | 1.72M | -4.84M | -5.72M |